As
filed with the U.S. Securities and Exchange Commission on August 2, 2023
Registration
No. 333-273174
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
AMENDMENT
NO. 3
to
FORM
S-1
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES
ACT OF 1933
INVO
BIOSCIENCE, INC.
(Exact
name of registrant as specified in its charter)
Nevada |
|
3841 |
|
20-4036208 |
(State
or other jurisdiction of
incorporation or organization) |
|
(Primary
Standard Industrial
Classification Code Number) |
|
(I.R.S.
Employer
Identification
Number) |
5582
Broadcast Court Sarasota, Florida, 34240
(978)
878-9505
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Steve
Shum
Chief
Executive Officer
INVO
Bioscience, Inc.
5582
Broadcast Court
Sarasota,
Florida 34240
(978)
878-9505
(Name,
address including zip code, and telephone number, including area code, of agent for service)
With
copies to:
Greg
Carney
Sheppard,
Mullin, Richter & Hampton LLP
333
South Hope Street, 43rd Floor
Los
Angeles, CA 90071
(213)
620-1780
Approximate
date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box: ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule l2b-2 of the Exchange Act.
Large
accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging Growth
Company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. D
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective
on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine
EXPLANATORY
NOTE
This
Amendment No. 3 (“Amendment No. 3”) to the Registration Statement on Form S-1 (File No. 333-273174) of INVO Bioscience, Inc.
(“Registration Statement”) is being filed solely for the purpose of filing the form of Warrant Agency Agreement as Exhibit
4.27. Accordingly, this Amendment No. 3 consists only of the facing page, this explanatory note, Item 16 of Part II of the Registration
Statement, the signature page, Exhibit 4.27 and the Exhibit Index. The remainder of the Registration Statement is unchanged and
therefore has not been included in this Amendment No. 3.
Item
16. Exhibits.
EXHIBIT
INDEX
Exhibit
No. |
|
Exhibit |
1.1**** |
|
Form
of Placement Agency Agreement |
3.1 |
|
Amended
and Restated Articles of Incorporation. Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the
Securities and Exchange Commission on January 5, 2009. |
3.2 |
|
Certificate
of Change. Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission
on May 22, 2020. |
3.3 |
|
By-Laws
of INVO Bioscience. Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form SB-2 filed with the Securities
and Exchange Commission on November 13, 2007. |
4.1 |
|
Description
of Capital Stock, filed as an Exhibit to our Annual Report on Form 10-K for the year ended December 31, 2022 and incorporated herein
by reference. |
4.2 |
|
Form
of Senior Secured Convertible Promissory Note, dated July 2009. Incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K filed with the Securities and Exchange Commission on July 17, 2009. |
4.3 |
|
Form
of Convertible Promissory Note Purchase Agreement, dated July 2009. Incorporated by reference to Exhibit 10.2 to the Current Report
on Form 8-K filed with the Securities and Exchange Commission on July 17, 2009. |
4.4 |
|
Form
of Convertible Promissory Note, dated January 2018. Incorporated by reference to Exhibit 4.3 to the Annual Report on Form 10-K filed
on April 16, 2019. |
4.5 |
|
Form
of Convertible Note Purchase Agreement, dated January 2018. Incorporated by reference to Exhibit 4.4 to the Annual Report on Form
10-K filed on April 16, 2019. |
4.6 |
|
Form
of Secured Convertible Note, dated May 2020. Incorporated by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q filed
with the Securities and Exchange Commission on May 15, 2020. |
4.7 |
|
Form
of Unit Purchase Option, dated May 2020. Incorporated by reference to Exhibit 4.2 to the Quarterly Report on Form 10-Q filed with
the Securities and Exchange Commission on May 15, 2020. |
4.8 |
|
Form
of Warrant, dated May 2020. Incorporated by reference to Exhibit 4.3 to the Quarterly Report on Form 10-Q filed with the Securities
and Exchange Commission on May 15, 2020. |
4.9 |
|
Form
of Placement Agent Warrant to Purchase Common Stock, filed as Exhibit 4.1 to our Current Report dated October 1, 2021 and filed with
the Securities and Exchange Commission on October 5, 2021 and incorporated herein by reference. |
4.10 |
|
Demand
Promissory Note between the registrant and JAG Multi Investments LLC, filed as Exhibit 4.1 to our Quarterly Report on Form 10-Q filed
with the Securities Exchange Commission on November 14, 2022 and incorporated herein by reference. |
4.11 |
|
Form
of Warrant, filed as Exhibit 4.5 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on January 5,
2023 and incorporated herein by reference. |
4.12 |
|
Form
of Debenture, filed as Exhibit 4.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on February
9, 2023 and incorporated herein by reference. |
4.13 |
|
Form
of Warrant, filed as Exhibit 4.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on February
9, 2023 and incorporated herein by reference. |
4.14 |
|
Form
of Debenture, filed as Exhibit 4.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on February
9, 2023 and incorporated herein by reference. |
4.15 |
|
Form
of Warrant, filed as Exhibit 4.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on February
9, 2023 and incorporated herein by reference. |
4.17 |
|
Form
of Convertible Promissory Note, filed as Exhibit 4.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on March 23, 2023 and incorporated herein by reference. |
4.18 |
|
Form
of Warrant, filed as Exhibit 4.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on March 23,
2023 and incorporated herein by reference. |
4.20 |
|
Form
of Pre-funded Warrant, filed as Exhibit 4.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on
March 28, 2023 and incorporated herein by reference. |
4.21 |
|
Form
of Private Placement Warrant, filed as Exhibit 4.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on March 28, 2023 and incorporated herein by reference. |
4.22 |
|
Form
of Placement Agent Warrant, filed as Exhibit 4.3 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on March 28, 2023 and incorporated herein by reference. |
4.23 |
|
Demand
Promissory Note dated July 10, 2023 issued by the registrant in favor of JAG Multi Investments LLC in the amount of $100,000, filed
as Exhibit 4.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 13, 2023 and incorporated
herein by reference. |
4.24**** |
|
Form
of Common Stock Purchase Warrant |
4.25**** |
|
Form
of Pre-Funded Warrant |
4.26**** |
|
Form
of Placement Agent Warrant |
4.27* |
|
Form
of Warrant Agency Agreement |
5.1**** |
|
Opinion
of Sheppard Mullin Richter & Hampton LLP |
10.1 |
|
Short
Term Note, dated March 5, 2009 between the registrant and Kathleen Karloff. Incorporated by reference to Exhibit 10.5 to the Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on May 15, 2009. |
10.2 |
|
Short
Term Note, dated May 19, 2019 between the registrant and Kathleen Karloff. Incorporated by reference to Exhibit 10.5 to the Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2009. |
10.3 |
|
Promissory
Note, dated August 9, 2016, between the registrant and Kavanaugh Rosenthal Peisch & Ford, LLP. Incorporated by reference to Exhibit
10.3 the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 16, 2019. |
10.4 |
|
Distribution
Agreement, dated November 12, 2018, between the Registrant and Ferring International Center S.A,. Incorporated by reference to Exhibit
10.4 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 16, 2019. |
10.5 |
|
Supply
Agreement, dated November 12, 2018, between the registrant and Ferring International Center S.A. Incorporated by reference to Exhibit
10.5 to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 16, 2019. |
10.6 |
|
Joint
Venture Agreement, dated January 13, 2020, between the registrant and Medesole Healthcare and Trading Private Limited, India. Incorporated
by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on January 16, 2020. |
10.7 |
|
Employment
Agreement, dated October 16, 2019, between the registrant and Steven Shum. Incorporated by reference to the Current Report on Form
8-K filed with the Securities and Exchange Commission on October 15, 2019. |
10.8 |
|
Employment
Agreement, dated January 15, 2020, between the registrant and Michael Campbell. Incorporated by reference to Exhibit 10.1 to the
Current Report on Form 8-K filed with the Securities and Exchange Commission on January 21, 2020. |
10.9 |
|
Commercial
Lease Agreement, dated May 1, 2019 between the registrant and PJ LLC. Incorporated by reference to Exhibit 10.9 to the Annual Report
on Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. |
10.10 |
|
2019
Stock Incentive Plan, incorporated by reference to the Registration Statement on Form S-8 with the Securities and Exchange Commission
on October 16, 2019. |
10.11 |
|
Pre-Incorporation
and Shareholders Agreement between INVO Centers, LLC, Francisco Arredondo, M.D. PLLC and Ramiro Ramirez Guiterrez. Incorporated by
reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on September 30, 2020. |
10.12 |
|
Distribution
Agreement, dated November 23, 2020, between the registrant and IDS Medical Systems (M) Sdn Bhda. Incorporated by reference to Exhibit
10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 25, 2020. |
10.13 |
|
Joint
Venture Agreement, dated November 23, 2020, between the registrant and SNS Nurni SDN BHD. Incorporated by reference to Exhibit 10.2
to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 25, 2020. |
10.14 |
|
Joint
Venture Agreement, dated November 23, 2020, between the registrant and Ginekaliks Dooel. Incorporated by reference to Exhibit 10.3
to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 25, 2020. |
10.15 |
|
Distribution
Agreement, dated December 2, 2020, between the registrant and Tasnim Behboud Arman. Incorporated by reference to Exhibit 10.1 to
the Current Report on Form 8-K filed with the Securities and Exchange Commission on December 8, 2020. |
10.16 |
|
Form
of Securities Purchase Agreement, dated May 2020. Incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission on May 15, 2020. |
10.17 |
|
Form
of Security Agreement, dated May 2020. Incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q filed with
the Securities and Exchange Commission on May 15, 2020. |
10.18 |
|
Form
of Registration Rights Agreement, dated May 2020. Incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission on May 15, 2020. |
10.19 |
|
Amendment
No. 1 to Distribution Agreement, between the registrant and Ferring International Center S.A. Incorporated by reference to Exhibit
10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 8, 2021. |
10.20 |
|
HRCFG
INVO LLC Limited Liability Company Agreement, dated March 10, 2021, between the registrant and HRCFG, LLC. Incorporated by reference
to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 15, 2021. |
10.21 |
|
Note,
dated March 10, 2021, between the registrant and HRCFG, LLC. Incorporated by reference to Exhibit 10.2 to the Current Report on Form
8-K filed with the Securities and Exchange Commission on March 15, 2021. |
10.22 |
|
Lease,
dated March 2021, with Trustmark National Bank filed as Exhibit 10.22 to our Annual Report on Form 10-K for the year ended December
31, 2020 and incorporated herein by reference. |
10.23 |
|
Partnership
Agreement dated April 9, 2021 between the registrant and Lyfe Medical, LLC, filed as Exhibit 10.1 to our Current Report on Form 8-K
dated April 9, 2021 and filed with the Securities and Exchange Commission on April 13, 2021 and incorporated by reference herein. |
10.24 |
|
Amended
and Restated Employment Agreement with Andrea Goren dated June 14, 2021, filed as Exhibit 10.1 to our Current Report on Form 8-K
dated June 14, 2021 and filed with the Securities and Exchange Commission on June 15, 2021 and incorporated herein by reference. |
10.25 |
|
Joint
Venture Agreement dated June 28, 2021 between INVO Centers, LLC and Bloom Fertility, LLC, filed as Exhibit 10.1 to our Current Report
on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and incorporated herein by
reference. |
10.26 |
|
Limited
Liability Company Agreement of Bloom INVO, LLC dated June 28, 2021, filed as Exhibit 10.2 to our Current Report on Form 8-K dated
June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and incorporated herein by reference. |
10.27 |
|
Management
Services Agreement dated June 28, 2021 between Bloom INVO LLC, Bloom Fertility LLC and Sue Ellen Carpenter, filed as Exhibit 10.3
to our Current Report on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and
incorporated herein by reference. |
10.28 |
|
INVOcell
Supply Agreement dated June 28, 2021 between the registrant and Bloom INVO LLC, filed as Exhibit 10.4 to our Current Report on Form
8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and incorporated herein by reference. |
10.29 |
|
Intellectual
Property License Agreement dated June 28, 2021 between Bloom INVO LLC and the registrant, filed as Exhibit 10.5 to our Current Report
on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and incorporated herein by
reference. |
10.30 |
|
Intellectual
Property License Agreement dated June 28, 2021 between Bloom INVO LLC, Bio X Cell Inc. and the registrant, filed as Exhibit 10.6
to our Current Report on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and
incorporated herein by reference. |
10.31 |
|
Sublease
Agreement dated June 29, 201 between Assure Fertility Partners of Atlanta II, LLC and Bloom INVO LLC, filed as Exhibit 10.7 to our
Current Report on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021 and incorporated
herein by reference. |
10.32 |
|
Guarantee
of Sublease made by the registrant in favor of Assure Fertility Partners of Atlanta II, LLC and Bloom INVO, LLC, filed as Exhibit
10.8 to our Current Report on Form 8-K dated June 28, 2021 and filed with the Securities and Exchange Commission on June 30, 2021
and incorporated herein by reference. |
10.33 |
|
Share
Purchase Agreement dated September 1, 2021 among Ernest Broome, Lyle Oberg, Richard Ross, Dr. Seang Lin Tan, the registrant and Effortless
IVF Canada Inc., filed as Exhibit 10.1 to our Current Report dated September 1, 2021 and filed with the Securities and Exchange Commission
on September 7, 2021 and incorporated herein by reference. |
10.34 |
|
Stock
Purchase Agreement dated September 30, 2021 between the registrant and Paradigm Opportunities Fund, LP, filed as Exhibit 10.1 to
our Current Report dated October 1, 2021 and filed with the Securities and Exchange Commission on October 4, 2021 and incorporated
herein by reference. |
10.35 |
|
Placement
Agent Agreement dated October 1, 2021 between the registrant and Paulson Investment Company, LLC, filed as Exhibit 10.1 to our Current
Report dated October 1, 2021 and filed with the Securities and Exchange Commission on October 5, 2021 and incorporated herein by
reference. |
10.36 |
|
Form
of Stock Purchase Agreement dated October 1, 2021 between the registrant and the purchasers set forth therein, filed as Exhibit 10.2
to our Current Report dated October 1, 2021 and filed with the Securities and Exchange Commission on October 5, 2021 and incorporated
herein by reference. |
10.37 |
|
Termination
Notice from Ferring International Center S.A. dated November 2, 2021, filed as Exhibit 10.1 to our Current Report on Form 8-K dated
November 2, 2021 and filed with the Securities and Exchange Commission on November 8, 2021 and incorporated herein by reference. |
10.38 |
|
Amendment
No. 1 to Stock Purchase Agreement dated November 29, 2021 between the registrant and Paradigm Opportunities Fund LP, filed as Exhibit
10.1 to our Current Report on Form 8-K dated November 29, 2021 and filed with the Securities and Exchange Commission on December
2, 2021 and incorporated herein by reference. |
10.39 |
|
Amendment
No. 2 to Stock Purchase Agreement dated November 29, 2021 between the registrant and Paradigm Opportunities Fund LP, filed as Exhibit
10.1 to our Current Report on Form 8-K dated December 31, 2021 and filed with the Securities and Exchange Commission on January 6,
2022 and incorporated herein by reference. |
10.41 |
|
Exclusive
Distribution Agreement between the registrant and Onesky Holding Limited dated May 13, 2022, filed as Exhibit 10.1 to our Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on May 16, 2022 and incorporated herein by reference. |
10.42 |
|
Lease
Agreement with INVO Centers, LLC dated May 23, 2022, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities
and Exchange Commission on May 26, 2022 and incorporated herein by reference. |
10.43 |
|
Second
Amended and Restated 2019 Stock Option Plan, filed as Appendix A to our Definitive Proxy Statement on Schedule 14A filed with the
Securities and Exchange Commission on August 25, 2022 and incorporated herein by reference. |
10.44 |
|
Distribution
Agreement by and between the registrant and Ming Mei Technology Co. Ltd. dated January 3, 2023, filed as Exhibit 10.1 to our Current
Report on Form 8-K filed with the Securities and Exchange Commission on January 5, 2023 and incorporated herein by reference. |
10.45 |
|
Form
of Convertible Promissory Note, filed as Exhibit 4.4 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on January 5, 2023 and incorporated herein by reference. |
10.46 |
|
Securities
Purchase Agreement dated January 4, 2023, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and Exchange
Commission on January 5, 2023 and incorporated herein by reference. |
10.47 |
|
Registration
Rights Agreement dated January 4, 2023, filed as Exhibit 10.2 to our Current Report on Form 8-K filed with the Securities and Exchange
Commission on January 5, 2023 and incorporated herein by reference. |
10.48 |
|
Securities
Purchase Agreement dated February 3, 2023, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and
Exchange Commission on February 9, 2023 and incorporated herein by reference. |
10.49 |
|
Registration
Rights Agreement to Debenture and Warrant dated February 3, 2023, filed as Exhibit 10.2 to our Current Report on Form 8-K filed with
the Securities and Exchange Commission on February 9, 2023 and incorporated herein by reference. |
10.50 |
|
Equity
Purchase Agreement dated February 3, 2023, filed as Exhibit 10.4 to our Current Report on Form 8-K filed with the Securities and
Exchange Commission on February 9, 2023 and incorporated herein by reference. |
10.51 |
|
Registration
Rights Agreement to Equity Purchase Agreement dated February 3, 2023, filed as Exhibit 10.5 to our Current Report on Form 8-K filed
with the Securities and Exchange Commission on February 9, 2023 and incorporated herein by reference. |
10.52 |
|
Asset
Purchase Agreement between the registrant, WFRSA and The Elizabeth Pritts Revocable Living Trust dated March 16, 2023, filed as Exhibit
10.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on March 20, 2023 and incorporated herein
by reference. |
10.53 |
|
Membership
Interest Purchase Agreement by and between the registrant and FLOW, IVF Science, LLC dated March 16, 2023, filed as Exhibit 10.2
to our Current Report on Form 8-K filed with the Securities and Exchange Commission on March 20, 2023 and incorporated herein by
reference. |
10.54 |
|
Securities
Purchase Agreement dated March 17, 2023, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and Exchange
Commission on March 23, 2023 and incorporated herein by reference. |
10.55 |
|
Registration
Rights Agreement dated March 17, 2023, filed as Exhibit 10.2 to our Current Report on Form 8-K filed with the Securities and Exchange
Commission on March 23, 2023 and incorporated herein by reference. |
10.56 |
|
Placement
Agency Agreement by and between the registrant and Maxim Group, LLC dated March 23, 2023, filed as Exhibit 1.1 to our Current Report
on Form 8-K filed with the Securities and Exchange Commission on March 28, 2023 and incorporated herein by reference. |
10.57 |
|
Amendment
to Securities Purchase Agreement dated July 7, 2023 between the registrant and Armistice Capital Master Fund Ltd., filed as Exhibit
10.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 7, 2023 and incorporated herein
by reference. |
10.58 |
|
Payoff
Commitment Agreement and Confession of Judgment dated July 7, 2023 between the registrant and Armistice Capital Master Fund Ltd.,
filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 7, 2023 and incorporated
herein by reference. |
10.59 |
|
Asset
Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin
Fertility and Reproductive Surgery Associates, S.C., a Wisconsin professional service corporation d/b/t Wisconsin Fertility Institute
(and The Elizabeth Pritts Revocable Living Trust filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities
and Exchange Commission on March 20, 2023 and incorporated herein by reference. |
10.60 |
|
Membership
Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility
Labs of Wisconsin, LLC, a Wisconsin limited liability company, IVF Science, LLC, a Wisconsin limited liability company owned by Wael
Megid, Ph.D. and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust, a Trust created under the laws of
the State of Wisconsin, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on March 20, 2023 and incorporated herein by reference. |
10.61 |
|
Closing
Agreement dated July 7, 2023 for the Asset Purchase Agreement referred to in Exhibit 10.59 above, filed as Exhibit 10.1 to our Current
Report on Form 8-K filed with the Securities and Exchange Commission on July 13, 2023. |
10.62 |
|
Closing
Agreement dated July 7, 2023 for the Membership Interest Purchase Agreement referred to in Exhibit 10.59 above, filed as Exhibit
10.2 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 13, 2023. |
10.63 |
|
Letter
Agreement dated July 10, 2023 with JAG Multi Investments LLC, filed as Exhibit 4.1 to our Current Report on Form 8-K filed with the
Securities and Exchange Commission on July 13, 2023. |
10.64 |
|
Amended
and Restated Letter Agreement dated July 21, 2023 with JAG Multi Investments LLC filed as Exhibit 10.2 to our Current Report on Form
8-K filed with the Securities and Exchange Commission on July 21, 2023 and incorporated herein by reference. |
10.65 |
|
Standard
Merchant Cash Advance Agreement, filed as Exhibit 10.1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission
on July 21, 2023 and incorporated herein by reference. |
10.66**** |
|
Form
of Securities Purchase Agreement |
21.1 |
|
Subsidiaries
filed as an Exhibit to our Annual Report on Form 10-K for the year ended December 31, 2022 and incorporated herein by reference. |
23.1**** |
|
Consents
of M&K CPAs, PLLC |
23.2 |
|
Consent
of Sheppard Mullin Richter & Hampton LLP (included as Exhibit 5.1). |
24.1**** |
|
Power
of Attorney (included on signature page) |
107**** |
|
Filing
Fee Table |
*
Filed herewith
**
Furnished herewith
***To
be filed by amendment
****Previously
filed
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the Registrant has duly caused this Amendment No. 3 to Registration Statement to be
signed on its behalf by the Undersigned, thereunto duly authorized, in the City of Sarasota, State of Florida on the August
2, 2023.
|
INVO
BIOSCIENCE, INC. |
|
|
|
|
By: |
/s/
Steven Shum |
|
Name: |
Steven
Shum |
|
Title: |
Chief
Executive Officer (Principal Executive Officer) |